Trials / Completed
CompletedNCT02468141
Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients
Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients: A Randomized Double Blinded Placebo Controlled Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Kyunghee University Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To determine efficacy and safety of Sipjeondaebo-tang for Cancer patients suffering from anorexia after chemotherapy. Sipjeondaebo-tang will be administered for 4 weeks, 3 times per day after a meal. Changes of FAACT scale, Anorexia VAS, Weight, BMI, Clinical laboratory test such as ACTH, Cortisol, Chrelin, IL-6, ESR, CRP will be measured and analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SJDBT | Sipjeondaebo-tang |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-06-01
- Completion
- 2016-09-01
- First posted
- 2015-06-10
- Last updated
- 2017-07-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02468141. Inclusion in this directory is not an endorsement.